Charles Natanson
#164,305
Most Influential Person Now
Researcher
Charles Natanson's AcademicInfluence.com Rankings
Charles Natansonengineering Degrees
Engineering
#7208
World Rank
#8572
Historical Rank
Electrical Engineering
#2227
World Rank
#2333
Historical Rank
Charles Natansoncomputer-science Degrees
Computer Science
#9720
World Rank
#10197
Historical Rank
Data Science
#243
World Rank
#248
Historical Rank
Computational Linguistics
#2388
World Rank
#2411
Historical Rank
Machine Learning
#4331
World Rank
#4380
Historical Rank
Download Badge
Engineering Computer Science
Charles Natanson's Degrees
- PhD Computer Science Stanford University
- Masters Electrical Engineering University of California, Berkeley
- Bachelors Mathematics University of California, Berkeley
Similar Degrees You Can Earn
Why Is Charles Natanson Influential?
(Suggest an Edit or Addition)Charles Natanson's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Intensive insulin therapy and pentastarch resuscitation in severe sepsis. (2008) (2747)
- Profound but reversible myocardial depression in patients with septic shock. (1984) (1334)
- Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. (1990) (1200)
- Anti-inflammatory therapies to treat sepsis and septic shock: a reassessment. (1997) (670)
- A circulating myocardial depressant substance in humans with septic shock. Septic shock patients with a reduced ejection fraction have a circulating factor that depresses in vitro myocardial cell performance. (1985) (624)
- Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock (1989) (584)
- Serial cardiovascular variables in survivors and nonsurvivors of human septic shock: heart rate as an early predictor of prognosis. (1987) (506)
- Selected Treatment Strategies for Septic Shock Based on Proposed Mechanisms of Pathogenesis (1994) (457)
- The coronary circulation in human septic shock. (1986) (453)
- Cell-free hemoglobin-based blood substitutes and risk of myocardial infarction and death: a meta-analysis. (2008) (437)
- Meta-analysis of acute lung injury and acute respiratory distress syndrome trials testing low tidal volumes. (2002) (421)
- Risk and the efficacy of antiinflammatory agents: retrospective and confirmatory studies of sepsis. (2002) (356)
- Meta-Analysis: The Effect of Steroids on Survival and Shock during Sepsis Depends on the Dose (2004) (344)
- Transfusion of older stored blood and risk of death: a meta‐analysis (2012) (317)
- Hemolysis-associated endothelial dysfunction mediated by accelerated NO inactivation by decompartmentalized oxyhemoglobin. (2005) (297)
- Depressed left ventricular performance. Response to volume infusion in patients with sepsis and septic shock. (1988) (289)
- Bundled care for septic shock: An analysis of clinical trials* (2010) (276)
- Excess deaths associated with tigecycline after approval based on noninferiority trials. (2012) (272)
- Gram-negative bacteremia produces both severe systolic and diastolic cardiac dysfunction in a canine model that simulates human septic shock. (1986) (263)
- N omega-amino-L-arginine, an inhibitor of nitric oxide synthase, raises vascular resistance but increases mortality rates in awake canines challenged with endotoxin (1992) (261)
- Surviving sepsis--practice guidelines, marketing campaigns, and Eli Lilly. (2006) (214)
- Role of endotoxemia in cardiovascular dysfunction and mortality. Escherichia coli and Staphylococcus aureus challenges in a canine model of human septic shock. (1989) (209)
- On-site physician staffing in a community hospital intensive care unit. Impact on test and procedure use and on patient outcome. (1984) (174)
- A meta-analysis of N-acetylcysteine in contrast-induced nephrotoxicity: unsupervised clustering to resolve heterogeneity (2007) (162)
- Randomization in clinical trials of titrated therapies: Unintended consequences of using fixed treatment protocols* (2007) (158)
- The sirens' songs of confirmatory sepsis trials: selection bias and sampling error. (1998) (156)
- Mortality increases after massive exchange transfusion with older stored blood in canines with experimental pneumonia. (2013) (153)
- Eritoran tetrasodium (E5564) treatment for sepsis: review of preclinical and clinical studies (2011) (145)
- Anti-inflammatory therapies in sepsis and septic shock (2000) (142)
- Responses of left ventricular function in survivors and nonsurvivors of septic shock (1989) (140)
- Novel therapies for sepsis: a review. (2005) (134)
- A controlled trial of HA-1A in a canine model of gram-negative septic shock. (1993) (125)
- Tumor necrosis factor challenges in canines: patterns of cardiovascular dysfunction. (1992) (124)
- The effects of steroids during sepsis depend on dose and severity of illness: an updated meta-analysis. (2009) (123)
- Bacterial endotoxins and pathogenesis of Gram-negative infections: current status and future direction (1994) (117)
- Antibiotics versus cardiovascular support in a canine model of human septic shock. (1990) (105)
- Mechanical ventilation in ARDS: One size does not fit all. (2005) (104)
- Does prolonged storage of red blood cells cause harm? (2014) (104)
- Cardiopulmonary effects of granulocyte colony-stimulating factor in a canine model of bacterial sepsis. (1994) (90)
- Cardiovascular performance with E. coli challenges in a canine model of human sepsis. (1988) (89)
- Antitumor Necrosis Factor Therapy Is Associated With Improved Survival in Clinical Sepsis Trials: A Meta-Analysis* (2013) (84)
- Cardiopulmonary toxicity after liposomal amphotericin B infusion. (1991) (84)
- The evolving experience with therapeutic TNF inhibition in sepsis: considering the potential influence of risk of death (2011) (83)
- TNF but not IL-1 in dogs causes lethal lung injury and multiple organ dysfunction similar to human sepsis. (1991) (81)
- Persistence of Pneumocystis carinii in lung tissue of acquired immunodeficiency syndrome patients treated for pneumocystis pneumonia. (1984) (77)
- G-CSF during Escherichia coli versus Staphylococcus aureus pneumonia in rats has fundamentally different and opposite effects. (1999) (77)
- Recombinant human activated protein C in sepsis: Inconsistent trial results, an unclear mechanism of action, and safety concerns resulted in labeling restrictions and the need for phase IV trials (2003) (76)
- Safeguarding patients in clinical trials with high mortality rates. (2001) (73)
- From the bench to the bedside: the future of sepsis research. Executive summary of an American College of Chest Physicians, National Institute of Allergy and Infectious Disease, and National Heart, Lung, and Blood Institute Workshop. (1997) (72)
- Washing older blood units before transfusion reduces plasma iron and improves outcomes in experimental canine pneumonia. (2014) (65)
- Controlled trials of rG-CSF and CD11b-directed MAb during hyperoxia and E. coli pneumonia in rats. (1996) (64)
- Endotoxin in Septic Shock (1993) (64)
- The third component of complement protects against Escherichia coli endotoxin-induced shock and multiple organ failure (1994) (63)
- Differential hemodynamic effects of L-NMMA in endotoxemic and normal dogs. (1995) (63)
- Increasing evidence that the risks of rhAPC may outweigh its benefits (2007) (59)
- Pseudomonas aeruginosa compared with Escherichia coli produces less endotoxemia but more cardiovascular dysfunction and mortality in a canine model of septic shock. (1990) (58)
- Concerns over use of hydroxyethyl starch solutions (2014) (57)
- Nitrite reductase activity of hemoglobin as a systemic nitric oxide generator mechanism to detoxify plasma hemoglobin produced during hemolysis. (2008) (56)
- Preclinical trial of l-arginine monotherapy alone or with N-acetylcysteine in septic shock* (2006) (55)
- Leukocyte CD11b/18 antigen-directed monoclonal antibody improves early survival and decreases hypoxemia in dogs challenged with tumor necrosis factor. (1992) (53)
- rG-CSF reduces endotoxemia and improves survival during E. coli pneumonia. (1997) (52)
- Once is not enough: clinical trials in sepsis (2008) (50)
- Tyrphostin AG 556 improves survival and reduces multiorgan failure in canine Escherichia coli peritonitis. (1997) (50)
- Reassessing recombinant human activated protein C for sepsis: time for a new randomized controlled trial. (2005) (50)
- New strategies for combatting sepsis: the magic bullets missed the mark ... but the search continues. (1995) (49)
- Transfusion of older stored blood worsens outcomes in canines depending on the presence and severity of pneumonia (2014) (49)
- Plasma exchange does not improve survival in a canine model of human septic shock (1993) (49)
- Systematic analysis of hydroxyethyl starch (HES) reviews: proliferation of low-quality reviews overwhelms the results of well-performed meta-analyses (2012) (49)
- Continuous arteriovenous hemofiltration does not improve survival in a canine model of septic shock. (1995) (48)
- Therapeutic trial of reconstituted human high-density lipoprotein in a canine model of gram-negative septic shock. (1995) (47)
- Septic shock in humans (2020) (45)
- Systemic hemodynamic abnormalities and vasopressor therapy in sepsis and septic shock. (1992) (44)
- Anthrax lethal and edema toxins produce different patterns of cardiovascular and renal dysfunction and synergistically decrease survival in canines. (2010) (43)
- Transfusion of recently donated (fresh) red blood cells (RBCs) does not improve survival in comparison with current practice, while safety of the oldest stored units is yet to be established: a meta‐analysis (2016) (43)
- Red Blood Cell Transfusion: Precision vs Imprecision Medicine. (2015) (41)
- Acute hemorrhage in dogs: construction and validation of models to quantify blood loss. (1993) (41)
- Risk of death does not alter the efficacy of hydrocortisone therapy in a mouse E. coli pneumonia model (2008) (38)
- Practice Misalignments in Randomized Controlled Trials: Identification, Impact, and Potential Solutions (2009) (37)
- Effective dosing of lipid A analogue E5564 in rats depends on the timing of treatment and the route of Escherichia coli infection. (2006) (36)
- Hemodynamic effects of dopamine, norepinephrine, and fluids in a dog model of sepsis. (1995) (31)
- Substantiating the concerns about recombinant human activated protein C use in sepsis* (2004) (31)
- A canine model of septic shock: balancing animal welfare and scientific relevance. (2007) (31)
- Evidence Underpinning the Centers for Medicare & Medicaid Services' Severe Sepsis and Septic Shock Management Bundle (SEP-1) (2018) (30)
- Evidence Underpinning the U.S. Government–Mandated Hemodynamic Interventions for Sepsis: A Systematic Review (2018) (30)
- Neutrophil aggregating activity and septic shock in humans: Neutrophil aggregation by a C5a-like material occurs more frequently than complement component depletion and correlates with depression of systemic vascular resistance (1988) (29)
- Protection with Antibody to Tumor Necrosis Factor Differs with Similarly Lethal Escherichia coli versus Staphylococcus aureus Pneumonia in Rats (2003) (29)
- Haptoglobin improves shock, lung injury, and survival in canine pneumonia. (2018) (29)
- Differing effects of epinephrine, norepinephrine, and vasopressin on survival in a canine model of septic shock. (2004) (29)
- Cardiopulmonary effects of inhaled nitric oxide in normal dogs and during E. coli pneumonia and sepsis. (1998) (29)
- Tidal Volume and Plateau Pressure Use for Acute Lung Injury From 2000 to Present: A Systematic Literature Review* (2014) (29)
- Therapeutic trial of lipid X in a canine model of septic shock. (1993) (28)
- Antibiotic- and Fluid-Focused Bundles Potentially Improve Sepsis Management, but High-Quality Evidence Is Lacking for the Specificity Required in the Centers for Medicare and Medicaid Service's Sepsis Bundle (SEP-1). (2019) (27)
- Activated protein C in sepsis: emerging insights regarding its mechanism of action and clinical effectiveness (2004) (27)
- Role of endotoxemia in cardiovascular dysfunction and lethality: virulent and nonvirulent Escherichia coli challenges in a canine model of septic shock (1996) (27)
- Increasing the Efficacy of Anti-Inflammatory Agents Used in the Treatment of Sepsis (2003) (26)
- Hypothalamic-pituitary-adrenal axis in lethal canine Staphylococcus aureus pneumonia. (2014) (25)
- ICAM-1 and CD11b inhibition worsen outcome in rats with E. coli pneumonia. (1999) (25)
- Effects of intra-aortic balloon counterpulsation in a model of septic shock* (2009) (25)
- Antithrombotic therapies for sepsis: A need for more studies* (2006) (23)
- Beneficial effects of stress-dose corticosteroid therapy in canines depend on the severity of staphylococcal pneumonia (2012) (23)
- Intubation of the trachea in the critical care setting. (1985) (23)
- Efficacy of selective mineralocorticoid and glucocorticoid agonists in canine septic shock (2012) (22)
- Driving blind: instituting SEP-1 without high quality outcomes data. (2020) (22)
- In a canine pneumonia model of exchange transfusion, altering the age but not the volume of older red blood cells markedly alters outcome (2015) (22)
- Defining the standard of care in randomized controlled trials of titrated therapies (2004) (21)
- Proceedings of the Food and Drug Administration's public workshop on new red blood cell product regulatory science 2016 (2018) (21)
- Clinical trials in sepsis and septic shock in 1994 and 1995 (1995) (21)
- Acute G-CSF therapy is not protective during lethal E. coli sepsis. (2001) (20)
- Septic shock: the cardiovascular abnormality and therapy. (1989) (20)
- LACK OF PROTECTION BY Nw-METHYL-L-ARGININE (NMA), A NITRIC OXIDE SYNTHASE INHIBITOR, IN ENDOTOXIN (LPS)-CHALLENGED CANINES (1993) (20)
- Studies using a canine model to investigate the cardiovascular abnormality of and potential therapies for septic shock. (1990) (20)
- Transfused older stored red blood cells improve the clinical course and outcome in a canine lethal hemorrhage and reperfusion model (2015) (19)
- Response of the septic vasculature to prolonged vasopressor therapy with N(omega)-monomethyl-L-arginine and epinephrine in canines. (1998) (19)
- Endorsing performance measures is a matter of trust (2018) (19)
- Severity of sepsis alters the effects of superoxide anion inhibition in a rat sepsis model. (2004) (19)
- Recombinant human activated protein C, package labeling, and hemorrhage risks. (2009) (18)
- Long-term cost effectiveness of drotrecogin alfa (activated): an unanswered question. (2003) (18)
- An Analysis of Clinical Trials of Mediator-Specific Anti-Inflammatory Agents (1999) (18)
- TGF-beta1 increases microbial clearance but worsens lung injury during Escherichia coli pneumonia in rats. (2003) (18)
- Parenteral irons versus transfused red blood cells for treatment of anemia during canine experimental bacterial pneumonia (2017) (18)
- The importance of usual care control groups for safety monitoring and validity during critical care research (2008) (18)
- Should we continue to target the platelet-activating factor pathway in septic patients? (2004) (17)
- Recombinant Human Activated Protein C in Sepsis: Assessing Its Clinical Use (2004) (16)
- Misrepresenting “Usual Care” in Research: An Ethical and Scientific Error (2020) (15)
- In vivo reduction of cell‐free methemoglobin to oxyhemoglobin results in vasoconstriction in canines (2013) (15)
- Neutrophil inhibition with L-selectin-directed MAb improves or worsens survival dependent on the route but not severity of infection in a rat sepsis model. (2005) (15)
- Risks of restrictive red blood cell transfusion strategies in patients with cardiovascular disease (CVD): a meta‐analysis (2018) (14)
- Effects of L-NMMA and fluid loading on TNF-induced cardiovascular dysfunction in dogs. (1998) (14)
- Walk a mile in whose shoes? (2010) (14)
- The efficacy of drotrecogin alfa depends on severity of illness. (2004) (14)
- Usual Care and Informed Consent in Clinical Trials of Oxygen Management in Extremely Premature Infants (2016) (13)
- Angeli's salt counteracts the vasoactive effects of elevated plasma hemoglobin. (2012) (13)
- Risk of death and the efficacy of eritoran tetrasodium (E5564): design considerations for clinical trials of anti-inflammatory agents in sepsis. (2010) (13)
- Serial measures of total body oxygen consumption in an awake canine model of septic shock. (1996) (12)
- Separating practice guidelines from pharmaceutical marketing. (2007) (12)
- Sympathetic Blockade in a Canine Model of Gram-Negative Bacterial Peritonitis (2003) (12)
- Factors that determine the hemodynamic response to inhalation anesthetics. (1991) (12)
- Defining normal adrenal function testing in the intensive care unit setting: A canine study* (2010) (12)
- Granulocyte colony-stimulating factor has differing effects comparing intravascular versus extravascular models of sepsis. (2004) (11)
- The relevance of practice misalignments to trials in transfusion medicine (2010) (11)
- Increasing doses of pentoxifylline as a continuous infusion in canine septic shock. (1999) (11)
- Echocardiography, pulmonary artery catheterization, and radionuclide cineangiography in septic shock (1994) (11)
- Growing insights into the potential benefits and risks of activated protein C administration in sepsis: a review of preclinical and clinical studies (2009) (10)
- The influence of the storage lesion(s) on pediatric red cell transfusion (2015) (9)
- Positive end expiratory pressure in adults. (1984) (9)
- Corticosteroids for septic shock. (2004) (8)
- More on the Age of Transfused Red Cells. (2015) (8)
- Clinical practice: Blood-transfusion decisions not simple (2015) (8)
- Early goal-directed therapy reduced mortality and multiorgan dysfunction in severe sepsis or septic shock. (2002) (8)
- Clinical trials in sepsis: an update (2000) (7)
- Incomplete financial disclosure in a study of cell-free hemoglobin-based blood substitutes and risks of myocardial infarction and death. (2008) (7)
- Corticosteroid therapy for severe sepsis and septic shock. (2009) (7)
- Haptoglobin therapy has differential effects depending on severity of canine septic shock and cell‐free hemoglobin level (2019) (6)
- Recombinant human activated protein C in sepsis: previous concerns and current usage (2004) (6)
- Sepsis Trials What Have We Learned (1999) (6)
- Looking back on HA-1A. (1994) (6)
- Impact of different standard red blood cell storage temperatures on human and canine RBC hemolysis and chromium survival (2018) (6)
- Tidal Volumes in Acute Respiratory Distress Syndrome—One Size Does Not Fit All (2006) (6)
- ANTIBIOTICS, FLUIDS AND DOPAMINE IN A LETHAL CANINE MODEL OF SEPTIC SHOCK (SS): EFFECTS ON SURVIVAL (1988) (6)
- Effects of Respiratory Muscle Afferent on the Breathing and the Afferent Hypothesis (2001) (6)
- Rethinking the Anti-Inflammatory Approach to Septic Shock (1996) (6)
- SEVERE REVERSIBLE MYOCARDIAL DEPRESSION IN SEPTIC SHOCK (1983) (6)
- ELEVATED C5A LEVELS IN PATIENTS WITH SEPTIC SHOCK (1985) (5)
- Evidence Underpinning the Centers for Medicare & Medicaid Services' Severe Sepsis and Septic Shock Management Bundle (SEP-1) (2018) (5)
- DEPRESSED VENTRICULAR PERFORMANCE IN RESPONSE TO VOLUME INFUSION IN PATIENTS WITH SEPTIC SHOCK (1986) (5)
- Management of critically ill patients (1999) (5)
- Inhaled nebulized nitrite and nitrate therapy in a canine model of hypoxia-induced pulmonary hypertension. (2019) (5)
- HEMODYNAMIC EFFECTS OF TUMOR NECROSIS FACTOR (TNF) INFUSIONS IN CONSCIOUS DOGS (1988) (4)
- Monoclonal anti endotoxin antibodies as therapy in a canine model of human septic shock (1990) (4)
- The Role of Endotoxin in Bacterial Septic Shock (1993) (4)
- 202 THE NEUTROPHIL AS A THERAPEUTIC TARGET IN SEPTIC SHOCK (1995) (4)
- PROPHYLACTIC HIGH-DOSE Nω-MONOMETHYL-L-ARGININE PREVENTS THE LATE CARDIAC DYSFUNCTION ASSOCIATED WITH LETHAL TUMOR NECROSIS FACTOR-α CHALLENGE IN DOGS (2005) (4)
- Chapter 22 – Meta-analysis of Clinical Trials (2018) (3)
- 200 SELECTED TREATMENT STRATEGIES FOR SEPTIC SHOCK BASED ON PROPOSED MECHANISMS OF PATHOGENESIS (1995) (3)
- 199 NITRIC OXIDE IN SEPSIS: ROLE IN INFLAMMATION AND SHOCK (1995) (3)
- Prophylactic high-dose N(omega)-monomethyl-L-arginine prevents the late cardiac dysfunction associated with lethal tumor necrosis factor-alpha challenge in dogs. (2005) (3)
- Elevated plasma levels of limulus amoebocyte lysate- reactive material. Authors' reply (2006) (3)
- Mortality in patients with hypovolemic shock treated with colloids or crystalloids. (2014) (3)
- ANTIBODY AGAINST LEUKOCYTE CD18 MEMBRANE PROTEIN DOES NOT IMPROVE OUTCOME IN A CANINE MODEL OF HUMAN SEPSIS (1992) (3)
- CARDIOPULMONARY EFFECTS OF INHALED NITRIC OXIDE IN CANINE LOBAR AND DIFFUSE GRAM-NEGATIVE PNEUMONIA (1993) (2)
- Bacterial septic shock (1989) (2)
- L-SELECTIN DIRECTED MAb INCREASES OR DECREASES SURVIVAL DEPENDENT ON SITE BUT NOT SEVERITY OF INFECTION IN RATS (1998) (2)
- PENTOXIFYLLINE CAN INCREASE TUMOR NECROSIS FACTOR LEVEL AND DECREASE SURVIVAL IN A CANINE MODEL OF GRAM-NEGATIVE SEPTIC SHOCK (1993) (2)
- Mechanistic Insights into Cell-free Hemoglobin-induced Injury During Septic Shock. (2021) (2)
- ABILITY OF ENDOTOXIN AND HEAT-STABLE COMPONENTS OF TWO STRAINS OF E. COU TO PRODUCE LETHALITY IN CANINE SEPTIC SHOCK (1990) (2)
- 201 ANTICYTOKINE THERAPIES IN SEPTIC SHOCK (1995) (2)
- TUMOR NECROSIS FACTOR BUT NOT INTER-LEUKIN-1 INDUCES SUSTAINED BUT REVERSIBLE HYPOXEMIA, ALVEOLAR PROTEIN AND NEUTROPHIL ACCUMULATION, AND HEMODYNAMIC DEPRESSION IN DOGS (1990) (2)
- Transfusion of fresh vs. older red blood cells in the context of infection (2015) (2)
- In reply to “Transfusion of older blood and risk of death: unanswered questions” (2012) (2)
- Meta-analysis Risk of Myocardial Infarction and Death : A Cell-Free Hemoglobin-Based Blood Substitutes and Supplementary material (2008) (1)
- Neutrophil-Directed Therapies in Sepsis: Studies in a Canine Model (1995) (1)
- Selective Tumor Necrosis Factor Inhibitors' Effect On Survival In Septic Shock: A Meta-Analysis (2012) (1)
- CHANGES IN LEFT VENTRICULAR FUNCTION IN HUMANS WITH SEPTIC SHOCK (1986) (1)
- 809-3 Coronary artery bypass grafting without cardiopulmonary bypass increases survival rate and decreases morbidity: A meta-analysis (2004) (1)
- Academic Centers Investigating ARDS/ALI Therapies From 2000-2007: Tidal Volume (TV) Practices Differ Outside Vs. Within Randomized Controlled Trials (RCTs) (2012) (1)
- Anti-Inflammatory Therapy in Sepsis (2001) (1)
- Antithrombosis Trials: Should we test therapeutic heparin adjusted based on activated partial thromboplastin time in septic shock? (2009) (1)
- Red Blood Cell Transfusion (2012) (1)
- THERAPEUTIC TRIAL OF RECONSTITUTED HUMAN HIGH DENSITY UPOPROTEIN IN A DOG MODEL OF GRAM-NEGATIVE SEPTIC SHOCK: PRELIMINARY RESULTS (1993) (1)
- Meta-analysis of Clinical Trials (2012) (1)
- RBC Storage Lesion Studies in Humans and Experimental Models of Shock (2020) (1)
- EFFECT OF SEPTIC SHOCK ON CARDIOVASCULAR RESPONSES TO DOPAMINE (DA) AND NOREPINE PHRINE (NE) IN A CONSCIOUS CANINE MODEL (1993) (1)
- Forums for Expressing Concerns (2005) (1)
- THE RELATIONSHIP OF OXYGEN CONSUMPTION TO OXYGEN DELIVERY DIFFERS IN ANESTHETIZED VS CONSCIOUS DOGS (1990) (1)
- The anti-inflammatory approach to septic shock (1997) (1)
- Human and Canine Septic Shock: Studies of Cardiovascular Abnormality, Mediators, and Therapies (1990) (1)
- THE CARDIOVASCULAR RESPONSE TO VOLUME LOADING DURING INHALATIONAL ANESTHESIA (1989) (1)
- EARLY EPINEPHRINE INFUSION PREVENTS LATE MYOCARDIAL DEPRESSION AND ACCELERATES CARDIAC RECOVERY IN A LARGE ANIMAL MODEL OF SEPTIC SHOCK (2022) (0)
- Invited Topic: Individualized Care Is Superior to Standardized Care for the Majority of Critically Ill Patients. (2020) (0)
- FLUID LOADING ELIMINATES DIFFERENCES IN CARDIOVASCULAR RESPONSES TO DOPAMINE AND NOREPINEPHRINE IN AWAKE DOGS (1990) (0)
- LEFT VENTRICULAR (LV) COMPLIANCE (C) INCREASES DURING SEPTIC SHOCK (SS) IN DOGS (1987) (0)
- ENDOTOXEMIA DURING ANTIBIOTIC TREATMENT IN A CANINE MODEL OF SEPTIC SHOCK (1987) (0)
- THE EJECTION FRACTION PREDICTS SURVIVAL IN A CANINE MODEL THAT SIMULATES HUMAN SEPTIC SHOCK (1986) (0)
- Drotrecogin alfa (activated) (recombinant human activated protein C) for the treatment of severe sepsis. Pro and con (2003) (0)
- MICROORGANISM VIABILITY AFFECTS CARDIAC DYSFUNCTION AND MORTALITY IN CANINE SEPTIC SHOCK (SS): VIABILITY IS MORE IMPORTANT TO STAPII AUREUS (SA) THAN E. COLI (EC) (1987) (0)
- Using Secondary Data in Statistical Analysis (2007) (0)
- In canine bacterial pneumonia circulating granulocyte counts determine outcome from donor cells (2020) (0)
- DEVELOPMENT OF A VENTILATED CANINE MODEL OF SEPTIC SHOCK: 486 (2004) (0)
- Response to comments by Plataki and Williams (2007) (0)
- ANTIBODY AGAINST NEUTROPHIL ADHESION COMPLEX CDW18 DOES NOT IMPROVE SURVIVAL OR PREVENT CARDIOPULMONARY ABNORMALITIES AFTER TUMOR NECROSIS FACTOR INFUSION IN DOGS (1990) (0)
- DIFFERENT MICROORGANISMS PRODUCE SIMILAR SEVERE SYSTOLIC MYOCARDIAL DYSFUNCTION IN A CANINE MODEL THAT SIMULATES HUMAN SEPSIS (1986) (0)
- THE EJECTION FRACTION CORRELATES WITH THE SLOPE OF THE FRANK-STARLING RELATIONSHIP IN A CONSCIOUS DOG MODEL THAT SIMULATES HUMAN SEPTIC SHOCK (1986) (0)
- NON-SURVIVORS IN EXPERIMENTAL SEPTIC SHOCK EXHIBIT LV EDEMA AND THE ABSENCE OF LV DILATATION (2023) (0)
- Chapter 16 – Using Secondary Data in Statistical Analysis (2002) (0)
- A410 COMPARED TO ENFLURANE, ISOFLURANE PRODUCES LESS DEPRESSION OF THE STROKE VOLUME AND AUTONOMMIC RESPONSE OF CANINES GIVEN PHENYLEPHRINE (1990) (0)
- Stem cell therapy : A “ magic bullet ” for cardiomyopathies ? (2013) (0)
- Measuring Impact: Citation Rates and the Quest to Identify Meaningful Clinical Research in Critical Care Medicine. (2016) (0)
- DIFFERENT MICROORGANISMS PRODUCE SIMILAR HEMODYNAMIC CHANGES, BUT DIFFERENT ENDOTOXIN CONCENTRATIONS, IN A CANINE MODEL OF SEPTIC SHOCK (1986) (0)
- CARDIAC AND PERIPHERAL VASCULAR RESPONSE TO RAPID VOLUME INFUSION IN CONSCIOUS DOGS (1987) (0)
- ENDOTOXIN ADMINISTRATION TO DOGS SIMULATES THE CARDIOVASCULAR PROFILE OF HUMAN SEPTIC SHOCK (SS) (1987) (0)
- ARTERIAL BASE DEFICIT IS AN ACCURATE INDICATOR OF VOLUME LOSS IN CANINE HEMORRHAGE (1991) (0)
- Reply to McGovern and Quintana (2012) (0)
- THE THIRD COMPONENT OF COMPLEMENT PROTECTS AGAINST ENDOTOXIN-INDUCED ORGAN DAMAGE (1993) (0)
- In Canine Staphylococcus Aureus Pneumonia Circulating Granulocyte Counts Determine Survival and the Response to Donor Granulocyte Transfusion (2020) (0)
- Reply to Rossignol et al. (2006) (0)
- FENTANYL MAY DIRECTLY BLOCK CARDIAC B-AGONIST EFFECTS OF EPINEPHRINE IN DOGS (1993) (0)
- Red Blood Cell Storage: The Oxygen Paradox (2019) (0)
- THE PEAK SYSTOLIC PRESSURE - END SYSTOLIC VOLUME RATIO CORRELATES WITH CHANGES IN THE EJECTION FRACTION IN A CANINE MODEL OF SEPTIC SHOCK (1987) (0)
- Vasopressin on Survival in a Canine Model of Septic Shock (2004) (0)
- BACTERIAL SHOCK AND MYOCARDIAL FUNCTION H 559 Clot Implantation into Comprehensive Evaluation CE ' Peritoneum CE ' CE ' (0)
- The Use of Continuous Arteriovenous Hemofiltration or Plasma Exchange During Septic Shock (1996) (0)
- RECOMBINANT G-CSF INCREASES ENDOTOXIN CLEARANCE, REDUCES SERUM TNP LEVELS AND IMPROVES SURVIVAL IN A CANINE MODEL OF SEPTIC SHOCK (1994) (0)
- Hemolysis-Endothelial Dysfunction Syndrome: A Novel Paradigm of Disease Mechanism. (2004) (0)
- but not severity of infection in a rat sepsis model improves or worsens survival dependent on the route Neutrophil inhibition with L-selectin-directed MAb (2015) (0)
- Cell-Free Hemoglobin Challenge Worsens Lung Injury in Experimental Canine Staphylococcus Aureus Pneumonia Inducing Septic Shock (2020) (0)
- Is there enough evidence to support use of N-acetylcysteine in contrast-induced nephropathy? (2008) (0)
- Response to Open Peer Commentaries on “Misrepresenting ‘Usual Care’ in Research: An Ethical and Scientific Error” (2020) (0)
- Growing Evidence Supports A Relationship Between Sepsis-associated Risk Of Death And The Efficacy Of Sepsis Therapies With Anti-inflammatory Effects (2010) (0)
- Mineralocorticoid Trans-repression Of Endothelial Inflammation (2010) (0)
- Walk a Mile in Whose Shoes? Author's reply (2010) (0)
- Acknowledgement to reviewers (2009) (0)
- Clinical Characteristics of Patient Groups Patient code Age Sex Underlying disease Positive culture ( site ) Outcome yr cerebral glioblastoma Lymphoma Acute lymphocytic leukemia Mediastinitis ; coronary artery disease Lymphoma Myocardial infarction ; coronary artery disease Lymphoma Chronic granulom (2013) (0)
- VENTRICULAR PERFORMANCE The coronary circulation in human septic shock (2005) (0)
- EFFECTS OF PENTOTHAL ANESTHESIA, PARALYSIS, AND MECHANICAL VENTILATION ON OXYGEN DELIVERY AND CONSUMPTION WITH DECREASES IN BLOOD FLOW IN THE CANINE (1993) (0)
- GRANULOCYTE COLONY STIMULATING FACTOR TREATMENT DURING OXYGEN EXPOSURE IN NON-NEUTROPENIC RATS (1993) (0)
- THE EFFECTS OF INTRAVENOUS INFUSION OF TUMOR NECROSIS FACTOR (TNF) ON CANINE PULMONARY (P) FUNCTION (1988) (0)
- Release to Blood in Gram-Negative Bacterial Infection in MCP-1 Intrapulmonary G-CSF Rescues Neutrophil Recruitment to the Lung and Neutrophil (2015) (0)
- DOSE AND IDIOSYNCRATIC RESPONSE AFFECT CARDIOVASCULAR PARAMETERS MORE THAN DRUG IN SIX DOGS GIVEN HALOTHANE, ENFLURANE, AND ISOFLURANE (1989) (0)
- LOSS OF LINEARITY OF THE FRANK-STARLING RELATIONSHIP DURING SEPSIS INDUCED VENTRICULAR DYSFUNCTION (1986) (0)
- Table L Clinical Characteristics of Patient Groups Patient code Age Sex Underlying disease Positive culture ( site ) Outcome yr cerebral glioblastoma Lymphoma Acute lymphocytic leukemia Mediastinitis ; coronary artery disease Lymphoma Myocardial infarction ; coronary artery disease Lymphoma Chronic (2013) (0)
- Factors Influencing the Efficacy of Mediator‐Specific Anti‐Inflammatory, Glucocorticoid, and Anticoagulant Therapies for Sepsis (2010) (0)
- Thecoronarycirculation inhumanseptic shock (2011) (0)
- Evaluating guidelines for critical care: a need for detail (2010) (0)
- Medical Guidelines and Performance Measures: The Need to Keep Them Free of Industry Influence (2008) (0)
- Modeling current practices in critical care comparative effectiveness research (2022) (0)
- MULTI-MODALITY EVOKED POTENTIALS MONITORING IN ALERT, UNAN-ESTHETIZED DOGS (1988) (0)
- Comparative effectiveness research in critically ill patients: risks associated with mischaracterising usual care. (2020) (0)
- THE EFFECTS OF CATECHOLAMINES (CTE) ON CARDIOVASCULAR (CV) FUNCTION IN A CANINE MODEL OF HUMAN SEPTIC SHOCK (SS) (1988) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Charles Natanson?
Charles Natanson is affiliated with the following schools:
